Quantum-Si disclosed that it received a Nasdaq delisting notification after its shares traded below the $1 minimum bid price for 30 consecutive business days. The Branford, Connecticut-based company now has 180 calendar days—until January 19, 2027—to regain compliance by trading at $1 or above for 10 consecutive business days. Quantum-Si said it intends to monitor its closing bid and consider available options to meet the requirement. The company also recently pointed to partnerships, including with Cell Signaling Technology, and expansion steps such as securing a lease for office, lab, and manufacturing space in San Diego. For biotech investors, the immediate implication is not only liquidity and trading dynamics but also the potential pressure on financing, partnerships, and credibility when exchange compliance becomes a near-term corporate objective. While a delisting is not immediate, the notice raises the bar for near-term price stability and can become a catalyst for additional capital strategies.